Cardiac multi-marker strategy for effective diagnosis of acute myocardial infarction

Heart-type fatty acid-binding protein (H-FABP) is a heart-specific and highly sensitive biomarker for early diagnosis of acute myocardial infarction (AMI). We investigated the effectiveness of H-FABP for diagnosis of AMI in patients with different ethnic background and different time from symptom on...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinica chimica acta 2010-11, Vol.411 (21), p.1781-1787
Hauptverfasser: Xu, Qin, Chan, Cangel P.Y., Cao, Xiao-yao, Peng, Peng, Mahemuti, Maisumu, Sun, Qi, Cheung, Kwan-yee, Ip, Wai-sze, Zhou, Xin-rong, Hu, Ge-yang, Zhang, Xiao-feng, Jielile, Jiasharete, Li, Yao-dong, Ren, Rong, Glatz, Jan F.C., Renneberg, Reinhard
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Heart-type fatty acid-binding protein (H-FABP) is a heart-specific and highly sensitive biomarker for early diagnosis of acute myocardial infarction (AMI). We investigated the effectiveness of H-FABP for diagnosis of AMI in patients with different ethnic background and different time from symptom onset. Venous blood was withdrawn from consecutive patients with acute chest pain admitted to the First Affiliated Hospital of Xinjiang Medical University. The blood samples were used for measurement of creatine kinase MB (CK-MB) and cardiac troponin I (cTnI) using Beckman Coulter DC-800 analyzer, and detection of H-FABP using a one-step bedside immunotest. Two hundred and eighty-nine patients admitted within 12 h after the onset of symptoms were recruited in the study. The H-FABP immunotest was found to have higher diagnostic accuracy than cTnI and CK-MB in patients admitted within 3 h. The combination of H-FABP and cTnI was found to have the highest diagnostic accuracy (91%) among different cardiac markers and the other combinations. It gave the highest sensitivity [96% (95% CI: 91–98%)] and a comparable specificity [84% (95% CI: 76–89%)] to cTnI alone. A cardiac panel consisting of H-FABP and troponin is recommended.
ISSN:0009-8981
1873-3492
DOI:10.1016/j.cca.2010.07.033